Loading peptide directory…
Side-by-side
Pick up to 3 peptides and see their key facts side by side. Useful for narrowing a search before deciding which page to read in full.
1 of 3 selected.
| Field | Last updated |
|---|---|
| Aliases | 5-amino-1-methylquinolinium, 5A1MQ, NNMT inhibitor (membrane-permeable) |
| Category | Metabolic |
| Formula | C₁₀H₁₁IN₂ |
| Molecular weight | 286.12 Da |
| Half-life | hours (preclinical, rodent) |
| Mechanism (summary) | 5-Amino-1MQ (5-amino-1-methylquinolinium) is not a peptide but is frequently marketed alongside peptides. In the reviewed sources it remains experimental, with no approved human indication and no human clinical efficacy program that could be verified from primary sources. |
| Dosing notes | The clearest published in-vivo regimen is 20 mg/kg subcutaneously three times daily in diet-induced obese mice. Human dosing is unspecified — no validated regimen exists. |
| Storage |
Unspecified in authoritative sources reviewed. Research-grade small-molecule handling: dry, dark, room-temperature or refrigerated storage per supplier guidance; protect from moisture and light. |
| Read more | Full reference → |
|---|